CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020
30 juil. 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Resumes CB4211 Phase 1b Clinical Trial
07 juil. 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at Sachs Novel Coronavirus Investment Forum
06 juil. 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering
30 juin 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Founder Dr. Nir Barzilai’s New Book “AGE LATER” Reveals that Aging Can Be Seen as a Preventable Disease
17 juin 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020
02 juin 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference
27 mai 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Reports First Quarter 2020 Financial Results and Provides Business Update
14 mai 2020 16h02 HE
|
CohBar, Inc.
MENLO PARK, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role
13 mai 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides
05 mai 2020 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...